In January of 2015, the American Academy of Microbiology elected 79 new Fellows.
Fellows of the Academy are elected annually through a highly selective, peer-review process, based on their records of scientific achievement and original contributions that have advanced microbiology.
MINNEAPOLIS/ST. PAUL - February 19, 2015 – A new comprehensive analysis from the Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota, involving leading International Ebola researchers, examines what is known about transmission of the Ebola virus and cautions that the public health community should not rule out the possibility of respiratory transmission. Prior to the current Ebola epidemic in West Africa there have been only 24 reported Ebola outbreaks with approximately 2,400 cases reported over the previous 39 years. Evidence suggests that direct patient contact and contact with infectious body fluids are the primary modes for Ebola virus transmission, however, this evidence is based on a limited number of studies.
WASHINGTON, DC – February 17, 2015 - The typical Escherichia coli, the laboratory rat of microbiology, is a tiny 1-2 thousandths of a millimeter long. Now, by blocking cell division, two researchers at Concordia University in Montreal have grown E. coli that stretch three quarters of a millimeter. That’s up to 750 times their normal length. The research has potential applications in nanoscale industry, and may lead to a better understanding of how pathogens work. The study is published ahead of print on February 17 in the Journal of Bacteriology, a journal of the American Society for Microbiology.
Washington, DC - February 13, 2015 - According to a multinational clinical trial involving nearly 20,000 young women, the human papilloma virus vaccine, Cervarix, not only has the potential to prevent cervical cancer, but was effective against other common cancer-causing human papillomaviruses, aside from just the two HPV types, 16 and 18, which are responsible for about 70 percent of all cases. That effectiveness endured for the study’s entire follow-up, of up to four years. The research was published February 4 in Clinical and Vaccine Immunology, a journal of the American Society for Microbiology.
Washington, DC - January 20, 2015 - Researchers have tracked the genetic mutations that have occurred in the Ebola virus during the last four decades. Their findings, published inmBio®, the online open-access journal of the American Society for Microbiology, identified changes in the current West African outbreak strain that could potentially interfere with experimental, sequence-based therapeutics.
Washington, DC - January 13, 2015 - Treating surfaces with cold atmospheric pressure plasma (CAPP) may reduce the risk of transmitting norovirus, a contagious virus leading to stomach pain, nausea and diarrhea, according to a new study.
WASHINGTON, DC - FEBRUARY 11, 2015 -- With minor tinkering, a peptide—a tiny protein—from the skin of a frog could be fashioned into a novel antibiotic that would lack the toxic byproducts of some more conventional drugs. More importantly, such peptides would represent a new class of antibiotics, at a time when new classes are sorely needed as resistance rises among existing classes. The research was published online, 26 January 2015, in Antimicrobial Agents and Chemotherapy, a journal of the American Society for Microbiology.
Washington, DC - February 10, 2015 - An experimental medication that targets a protein in Ebola virus called VP24 protected 75% of a group of monkeys that were studied from Ebola virus infection, according to new research conducted by the U.S. Army, in collaboration with Sarepta Therapeutics, Inc. The study was published this week in mBio®, the online open-access journal of the American Society for Microbiology
Washington, DC – February 3, 2015 – Environmental factors like mode of delivery and duration of gestation may affect how infants’ gut bacteria mature, and that rate could help predict later body fat, international researchers from the EpiGen consortium have found in collaboration with scientists at Nestlé Research Center in Switzerland. The work is published this week in mBio®, the online open-access journal of the American Society for Microbiology.
Washington, DC - January 20, 2015 - A new biologic drug prevented death when administered to mice a week in advance of lethal challenge with influenza H7N9, a disease that has shown a roughly 30 percent mortality rate in humans. The biologic had previously proven protective in mice against the pandemic 2009 H1N1 and the highly pathogenic H5N1 influenza viruses. “This suggests that our approach could work for any strain of the influenza virus,” says corresponding author Elena Govorkova, of St. Jude Children’s Research Hospital, Memphis, Tennessee. The research is published ahead of print in Antimicrobial Agents and Chemotherapy.
WASHINGTON, DC – June 10, 2014 - Scientists believe they have an explanation for the axiom that stress, emotional shock, or overexertion may trigger heart attacks in vulnerable people. Hormones released during these events appear to cause bacterial biofilms on arterial walls to disperse, allowing plaque deposits to rupture into the bloodstream, according to research published in published today in mBio®, the online open-access journal of the American Society for Microbiology.
Contact: Garth Hogan
Eighty-Seven Scientists Elected to the American Academy of Microbiology
Washington, DC—March 29, 2013—Eighty-seven microbiologists have been elected to Fellowship in the American Academy of Microbiology. Fellows of the Academy are elected annually through a highly selective, peer-review process, based on their records of scientific achievement and original contributions that have advanced microbiology. There are over 2,000 Fellows representing all subspecialties of microbiology, including basic and applied research, teaching, public health, industry, and government service. The new Fellows are as follows:
-Salim S. Abdool Karim, MBChB, Ph.D., Center for the AIDS Program of Research in South Africa, Durban
-Munirul Alam, Ph.D., International Centre for Diarrheal Disease Research, Bangladesh (Dhaka)
-Karen Arndt, Ph.D., University of Pittsburgh, PA
-Monsef Benkirane, Ph.D., Institut de Génétique Humaine, CNRS, Montpellier, France
-Jeffrey M. Bergelson, M.D., Children's Hospital of Philadelphia, University of Pennsylvania
-Marshall E. Bloom, M.D., Rocky Mountain Laboratories, NIAID/NIH, Hamilton, MT
-Elizaveta Bonch -Osmolovskaya, Ph.D., Winogradsky Institute of Microbiology RAS, Moscow, Russia
-Carlos Bustamante, Ph.D., University of California, Berkeley
-Michael Caparon, Ph.D., Washington University School of Medicine, St. Louis, MO
-Louise T. Chow, Ph.D., University of Alabama at Birmingham
-Jon Clardy, Ph.D., Harvard Medical School, Boston, MA
-Myron S. Cohen, M.D., University of North Carolina - Chapel Hill
-Richard Condit, Ph.D., University of Florida, Gainesville
-Tyrrell Conway, Ph.D., University of Oklahoma, Norman
-Peggy A. Cotter, Ph.D., University of North Carolina - Chapel Hill
-Blossom Damania, Ph.D., University of North Carolina - Chapel Hill
-Joseph DeRisi, Ph.D., University of California, San Francisco
-Tamara Lea Doering, M.D., Ph.D., Washington University School of Medicine, St. Louis, MO
-Valerian V. Dolja, Ph.D., Oregon State University, Corvallis
-Maria Gloria Domínguez-Bello, Ph.D., University of Puerto Rico, Rio Piedras
-Xinnian Dong, Ph.D., Duke University, Durham, NC
-Harold L. Drake, Ph.D., University of Bayreuth, Germany
-Nicole Dubilier, Ph.D., Max Planck Institute for Marine Microbiology, Bremen, Germany
-Stanislav Dusko Ehrlich, Ph.D., MetaGenoPoliS, Institut National de la Recherche Agronomique, Paris, France
-Michael Ehrmann, Ph.D., University Duisburg-Essen, Germany
-Paul T. Englund, Ph.D., Johns Hopkins University School of Medicine, Baltimore, MD
-Michael Follows, Ph.D., Massachusetts Institute of Technology, Cambridge
-Georg Fuchs, Ph.D., University of Freiburg, Germany
-Takema Fukatsu, Ph.D., National Institute of Advanced Industrial Science and Technology, Tsukuba, Japan
-Shou-Jiang Gao, Ph.D., University of Southern California, Los Angeles
-Mariano A. Garcia Blanco, M.D./Ph.D., Duke University and Duke-NUS Graduate Medical School, Singapore
-Partho Ghosh, Ph.D., University of California, San Diego
-Ursula Goodenough, Ph.D., Washington University, St. Louis, MO
-Michael W. Gray, Ph.D., Dalhousie University, Halifax, NS, Canada
-Maria J. Harrison, Ph.D., Boyce Thompson Institute for Plant Research, Ithaca, NY
-Steven M. Holland, M.D., Laboratory of Clinical Infectious Diseases, NIAID, NIH, Bethesda, MD
-James T. Hollibaugh, Ph.D., University of Georgia, Athens
-Terence Hwa, Ph.D., University of California, San Diego
-Michael Ibba, Ph.D., The Ohio State University, Columbus
-Janet Jansson, Ph.D., Earth Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA
-Vijay Juneja, Ph.D., USDA-ARS-Eastern Regional Research Center, Wyndmoor, PA
-Kami Kim, M.D., Albert Einstein College of Medicine, Bronx, NY
-Dennis Marc Klinman, M.D., Ph.D., NCI, Frederick, MD
-H. Clifford Lane, M.D., NIAID, NIH, Bethesda, MD
-Richard E. Lloyd, Ph.D., Baylor College of Medicine, Houston, TX
-Jennifer Jane Loros, Ph.D., The Audrey and Theodor Geisel School of Medicine at Dartmouth, Hanover, NH
-David A. Low, Ph.D., University of California, Santa Barbara
-Erich R. Mackow, Ph.D., Stony Brook University, NY
-Robert E. Mandrell, Ph.D, USDA, Albany, CA
-Robert L. Modlin, M.D., University of California, Los Angeles
-Søren Molin, Ph.D., The Technical University of Denmark, Lyngby
-Guido C. Mora, Ph.D., Universidad Andres Bello, Santiago, Chile
-Philip Murphy, M.D., NIAID, NIH, Bethesda, MD
-Xavier Nassif, M.D., Ph.D., Université Paris Descartes, Faculté de Médecine, Hôpital Necker-Enfants Malades, Paris, France
-Scott O'Neill, Ph.D., Monash University, Clayton, Australia
-R. John Parkes, Ph.D., Cardiff University, United Kingdom
-Matthew R. Parsek, Ph.D., University of Washington School of Medicine, Seattle
-Edward J. Pearce, Ph.D., Washington University School of Medicine, St Louis, MO
-Eric M. Phizicky, Ph.D., University of Rochester School of Medicine and Dentistry, NY
-Roger J. Pomerantz, M.D., F.A.C.P., Merck & Co., North Wales, PA
-Jacques Ravel, Ph.D., University of Maryland School of Medicine, Institute for Genome Sciences, Baltimore
-Forest Rohwer, Ph.D., San Diego State University, CA
-Susan M. Rosenberg, Ph.D., Baylor College of Medicine, Houston, TX
-Mirja S. Salkinoja-Salonen, Ph.D., University of Helsinki, Finland
-George P.C. Salmond, ScD., University of Cambridge, United Kingdom
-Stewart Shuman, M.D., Ph.D., Sloan-Kettering Institute for Cancer Research, MSKCC, New York, NY
-Vanessa Sperandio, Ph.D., University of Texas Southwestern Medical Center, Dallas, TX
-Alfred Spormann, Ph.D., Stanford University, CA
-Raymond J. St. Leger, Ph.D., University of Maryland, College Park
-Michael Starnbach, Ph.D., Harvard Medical School, Boston, MA
-Gregory Stephanopoulos, Ph.D., Massachusetts Institute of Technology, Cambridge
-Surachai Supattapone, M.D., Ph.D., D.Phil., The Audrey and Theodor Geisel School of Medicine at Dartmouth, Hanover, NH
-Kenneth S. Thomson, Ph.D., Creighton University, Omaha, NE
-Paula Traktman, Ph.D., Medical College of Wisconsin, Milwaukee
-B. Gillian Turgeon, Ph.D., Cornell University, Ithaca, NY
-Rodney Kim Tweten, Ph.D., University of Oklahoma Health Sciences Center, Oklahoma City
-Alex van Belkum, Ph.D., Ph.D., bioMerieux, S.A., La Balme les Grottes, France
-Jörg Vogel, Dr. rer. nat., University of Würzburg, Germany
-Michael Wagner, Ph.D., University of Vienna, Austria
-Mark J. Walker, Ph.D., Australian Infectious Diseases Research Centre, St. Lucia
-Alison Weiss, Ph.D., University of Cincinnati, OH
-Sean P. J. Whelan, Ph.D., Harvard Medical School, Boston, MA
-Bryan Raymond George Williams, Ph.D., Monash Institute of Medical Research, Monash University, Clayton, Australia
-George B. Witman, Ph.D., University of Massachusetts Medical School, Worcester
-Gerard D. Wright, Ph.D., McMaster University, Hamilton, ON, Canada
-Jiunn-Jong Wu, Ph.D., College of Medicine, National Cheng Kung University, Tainan, Taiwan
-Mark Young, Ph.D., Montana State University, Bozeman
For information about election to the Fellowship in the American Academy of Microbiology, please visit: http://academy.asm.org/index.php/fellows-info.
The American Academy of Microbiology is the honorific leadership group of the American Society for Microbiology. The mission of the Academy is to recognize scientific excellence, as well as foster knowledge and understanding in the microbiological sciences. More information on the Academy can be found online at http://academy.asm.org.
The American Society for Microbiology is the largest single life science society, composed of over 39,000 scientists and health professionals. ASM’s mission is to advance the microbiological sciences as a vehicle for understanding life processes and to apply and communicate this knowledge for the improvement of health and environmental and economic well-being worldwide. For more information, visit http://www.asm.org.
WASHINGTON, DC – March 12, 2013 – Slender bacterial nanowires require certain key amino acids in order to conduct electricity, according to a study to be published in mBio®, the online open-access journal of the American Society for Microbiology, on Tuesday, March 12.
WASHINGTON, DC – December 11, 2012 – The SARS epidemic of 2002-2003 was short-lived, but a novel type of human coronavirus that is alarming public health authorities can infect cells from humans and bats alike, a fact that could make the animals a continuing source of infection, according to a study to be published in mBio®, the online open-access journal of the American Society for Microbiology, on December 11. The new coronavirus, called hCoV-EMC, is blamed for five deaths and several other cases of severe disease originating in countries in the Middle East. According to the new results, hCoV-EMC uses a different receptor in the human body than the SARS virus, and can infect cells from a wide range of bat species and pigs, indicating there may be little to keep the virus from passing from animals to humans over and over again.
WASHINGTON, DC – December 4, 2012 -- New clues about the bacteria that cause Lyme disease could lead to a novel strategy to reduce infections, according to a study to be published in mBio®, the online open-access journal of the American Society for Microbiology, on December 4.
CONTACT: Jim Sliwa
WASHINGTON, DC -- June 21, 2010 -- Historic and culturally important artifacts, like all materials, are vulnerable to microbial attack. Cultural Heritage Microbiology, a new text from ASM Press, offers a synthesis of important scientific articles describing microbial deterioration of cultural heritage materials and methods for conserving these objects against this decay.
“No material is immune to microbial attack. Microorganisms have been shown to play a role in the deterioration of historic paintings, wood, paper, glass, textiles, metals waxes, polymers and coatings, and stone. Microbial processes can also be adapted to conserve and even restore heritage materials, pointing to the complex nature of microbial interactions with these irreplaceable materials,” says Ralph Mitchell of the Harvard School of Engineering and Applied Sciences, who co-edited the text with Christopher McNamara of the Harvard School of Public Health.
Cultural Heritage Microbiology assembles over twenty scientific papers published during the past two decades, each presenting a major advance in some facet of this complex field. These seminal articles, by a wide range of international experts, are grouped by the historic material affected. Each section is introduced by a thorough review, written for this volume, which serves to introduce and synthesize these past studies and to combine them with the latest cutting-edge findings to present the most current state of the field.
“The literature dealing with heritage microbiology is published in a wide range of locations, including sources from many disciplines and in many languages. Therefore we hope to provide scientists and conservators with important publications describing the major advances in our understanding of the microbial deterioration of cultural heritage materials,” says Mitchell.
This text is ideal for anyone concerned with recognizing and dealing with microbial deterioration of heritage materials. Professionals and students in microbiology, conservation science, archaeology, fine arts, architecture, museum conservation, and other fields will find here the most current knowledge and approaches to preserving cultural heritage objects for generations to come.
Cultural Heritage Microbiology has a list price of $169.95 and can be purchased through ASM Press online at http://estore.asm.org or through other online retailers.
ASM Press is the book publishing arm of the American Society for Microbiology (ASM), the oldest and largest single life science membership organization in the world. The ASM's mission is to promote research in the microbiological sciences and to assist communication between scientists, policy makers, and the public to improve health and foster economic well-being.